Skip to content

Adapting Daily Activity Performance Through Strategy Training

Closing the Gap: Early Intervention for Cognitive Disability After Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01934621
Acronym
ADAPTS
Enrollment
128
Registered
2013-09-04
Start date
2013-11-30
Completion date
2020-09-30
Last updated
2020-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Strategy Training, Attention Control

Keywords

Stroke, Rehabilitation, Cognition, Disability

Brief summary

Individuals with cognitive impairments after stroke sustain significant disability in their daily tasks, and account for a significant proportion of stroke-related healthcare costs. The proposed study examines a novel intervention, strategy training, that shows promise for helping individuals with stroke-related cognitive impairments reduce disability in daily tasks, which may lead to reductions in healthcare costs. We predict that strategy training will result in significantly greater independence 6 months after stroke compared to an attention control intervention, and that strategy training may reduce cognitive impairments.

Interventions

BEHAVIORALAttention Control

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* primary diagnosis of acute stroke * admission to acute inpatient rehabilitation * impairment in higher order cognitive functions (EXIT-14 ≥ 3)

Exclusion criteria

* pre-stroke diagnosis of dementia in the medical record * inability to follow two- step commands 80% of the time * severe aphasia (BDAE ≤ 1) * current major depressive, bipolar, or psychotic disorder * drug or alcohol abuse within 3 months

Design outcomes

Primary

MeasureTime frameDescription
Change in Independence with Daily ActivitiesBaseline to Month 6Moderate effect size of difference between groups in independence (measured with the Functional Independence Measure)

Secondary

MeasureTime frameDescription
Change in Executive FunctionsBaseline to Month 6Moderate effect size of difference between groups in independence (measured with selected indices of the Delis-Kaplan Executive Function System)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026